New published data confirms Nemluvio® (nemolizumab) can rapidly relieve itch and improve sleep in as early as two days in both atopic dermatitis and prurigo nodularis Press release
Galderma announces first patient enrollment in study to assess nemolizumab in adults with Chronic Pruritus of Unknown Origin Press release
Galderma opens up new chapter for Sculptra® with MDR certification and new expanded indication for body Press release
ASDS 2025: Compelling new data on Restylane, Sculptra and Relfydess highlight Galderma’s innovative Injectable Aesthetics portfolio and pipeline Press release
Galderma receives U.S. FDA approval for Restylane® Lyft™ for the enhancement of the chin profile Press release
AMWC Dubai: Galderma demonstrates Injectable Aesthetics leadership through updates on its scientific innovations and community education Press release
Galderma’s groundbreaking real-world study reveals the biological toll of modern living and urban environments on sensitive skin Press release
Galderma launches transformative skincare segment with Cetaphil’s new Skin Activator Hydrating & Firming Line, in partnership with actor and filmmaker Mariska Hargitay Press release
